148 related articles for article (PubMed ID: 31034880)
21. Validation of a simple inductively coupled plasma mass spectrometry method for detecting urine and serum iodine and evaluation of iodine status of pregnant women in Beijing.
Yu S; Yin Y; Cheng Q; Han J; Cheng X; Guo Y; Sun D; Xie S; Qiu L
Scand J Clin Lab Invest; 2018 Oct; 78(6):501-507. PubMed ID: 30261754
[TBL] [Abstract][Full Text] [Related]
22. Actual Anti-TNF Trough Levels Relate to Serum IL-10 in Drug-Responding Patients With Crohn's Disease.
Zapater P; Almenara S; Gutiérrez A; Sempere L; García M; Laveda R; Martínez A; Scharl M; Cameo JI; Linares R; González-Navajas JM; Wiest R; Rogler G; Francés R
Inflamm Bowel Dis; 2019 Jul; 25(8):1357-1366. PubMed ID: 30776076
[TBL] [Abstract][Full Text] [Related]
23. Comparisons of Serum Infliximab and Antibodies-to-Infliximab Tests Used in Inflammatory Bowel Disease Clinical Trials of Remicade®.
Marini JC; Sendecki J; Cornillie F; Popp JW; Black S; Blank M; Gils A; Van Stappen T; Hamann D; Rispens T; Thérien L; Chun K; Shankar G
AAPS J; 2017 Jan; 19(1):161-171. PubMed ID: 27600137
[TBL] [Abstract][Full Text] [Related]
24. Verification between Original and Biosimilar Therapeutic Antibody Infliximab Using nSMOL Coupled LC-MS Bioanalysis in Human Serum.
Iwamoto N; Yokoyama K; Takanashi M; Yonezawa A; Matsubara K; Shimada T
Curr Pharm Biotechnol; 2018; 19(6):495-505. PubMed ID: 29968534
[TBL] [Abstract][Full Text] [Related]
25. Biomonitoring of essential and toxic metals in single hair using on-line solution-based calibration in laser ablation inductively coupled plasma mass spectrometry.
Dressler VL; Pozebon D; Mesko MF; Matusch A; Kumtabtim U; Wu B; Sabine Becker J
Talanta; 2010 Oct; 82(5):1770-7. PubMed ID: 20875575
[TBL] [Abstract][Full Text] [Related]
26. Preconcentration and SERS-based determination of infliximab in blood by using a TNF-α-modified gold-coated copper oxide nanomaterial.
Muneer S; Ayoko GA; Islam N; Izake EL
Mikrochim Acta; 2019 Nov; 186(12):780. PubMed ID: 31729556
[TBL] [Abstract][Full Text] [Related]
27. Trough s-infliximab and antibodies towards infliximab in a cohort of 79 IBD patients with maintenance infliximab treatment.
Marits P; Landucci L; Sundin U; Davidsdottir L; Nilsson J; Befrits R; Wikström AC; Eberhardson M
J Crohns Colitis; 2014 Aug; 8(8):881-9. PubMed ID: 24486178
[TBL] [Abstract][Full Text] [Related]
28. Assay in serum of exchangeable copper and total copper using inductively coupled plasma mass spectrometry (ICP-MS): development, optimisation and evaluation of a routine procedure.
Daymond R; Curtis SL; Mishra V; Roberts NB
Scand J Clin Lab Invest; 2020 Dec; 80(8):630-639. PubMed ID: 32955383
[TBL] [Abstract][Full Text] [Related]
29. Detection of electrophoretically separated cytochromes P450 by element-labelled monoclonal antibodies via laser ablation inductively coupled plasma mass spectrometry.
Roos PH; Venkatachalam A; Manz A; Waentig L; Koehler CU; Jakubowski N
Anal Bioanal Chem; 2008 Nov; 392(6):1135-47. PubMed ID: 18626632
[TBL] [Abstract][Full Text] [Related]
30. Elemental Testing Using Inductively Coupled Plasma Mass Spectrometry in Clinical Laboratories.
Yang HS; LaFrance DR; Hao Y
Am J Clin Pathol; 2021 Jul; 156(2):167-175. PubMed ID: 33978166
[TBL] [Abstract][Full Text] [Related]
31. Infliximab trough levels are decreasing over time in patients with inflammatory bowel disease on maintenance treatment with infliximab.
Orfanoudaki E; Gazouli M; Foteinogiannopoulou K; Theodoraki E; Legaki E; Romanos I; Mouzas I; Koutroubakis IE
Eur J Gastroenterol Hepatol; 2019 Feb; 31(2):187-191. PubMed ID: 30543573
[TBL] [Abstract][Full Text] [Related]
32. Comparative analysis of the influence of clinical factors including BMI on adalimumab and infliximab trough levels.
Bond A; Asher R; Jackson R; Sager K; Martin K; Kneebone A; Philips S; Taylor W; Subramanian S
Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):271-6. PubMed ID: 26657455
[TBL] [Abstract][Full Text] [Related]
33. A Surface Plasmon Resonance-based assay to measure serum concentrations of therapeutic antibodies and anti-drug antibodies.
Beeg M; Nobili A; Orsini B; Rogai F; Gilardi D; Fiorino G; Danese S; Salmona M; Garattini S; Gobbi M
Sci Rep; 2019 Feb; 9(1):2064. PubMed ID: 30765716
[TBL] [Abstract][Full Text] [Related]
34. Proactive therapeutic drug monitoring of infliximab: a comparative study of a new point-of-care quantitative test with two established ELISA assays.
Afonso J; Lopes S; Gonçalves R; Caldeira P; Lago P; Tavares de Sousa H; Ramos J; Gonçalves AR; Ministro P; Rosa I; Vieira AI; Dias CC; Magro F;
Aliment Pharmacol Ther; 2016 Oct; 44(7):684-92. PubMed ID: 27507790
[TBL] [Abstract][Full Text] [Related]
35. A multiplex liquid chromatography tandem mass spectrometry method for the quantification of seven therapeutic monoclonal antibodies: Application for adalimumab therapeutic drug monitoring in patients with Crohn's disease.
Willeman T; Jourdil JF; Gautier-Veyret E; Bonaz B; Stanke-Labesque F
Anal Chim Acta; 2019 Aug; 1067():63-70. PubMed ID: 31047150
[TBL] [Abstract][Full Text] [Related]
36. Evolution of cytokines and inflammatory biomarkers during infliximab induction therapy and the impact of inflammatory burden on primary response in patients with Crohn's disease.
Billiet T; Cleynen I; Ballet V; Claes K; Princen F; Singh S; Ferrante M; Van Assche G; Gils A; Vermeire S
Scand J Gastroenterol; 2017 Oct; 52(10):1086-1092. PubMed ID: 28622097
[TBL] [Abstract][Full Text] [Related]
37. Changes in serum trough levels of infliximab during treatment intensification but not in anti-infliximab antibody detection are associated with clinical outcomes after therapeutic failure in Crohn's disease.
Steenholdt C; Bendtzen K; Brynskov J; Thomsen OØ; Munck LK; Christensen LA; Pedersen G; Kjeldsen J; Ainsworth MA
J Crohns Colitis; 2015 Mar; 9(3):238-45. PubMed ID: 25576753
[TBL] [Abstract][Full Text] [Related]
38. Monitoring functional serum antitumor necrosis factor antibody level in Crohn's disease patients who maintained and those who lost response to anti-TNF.
Yamada A; Sono K; Hosoe N; Takada N; Suzuki Y
Inflamm Bowel Dis; 2010 Nov; 16(11):1898-904. PubMed ID: 20310016
[TBL] [Abstract][Full Text] [Related]
39. Comparison of four analytical techniques based on atomic spectrometry for the determination of total tin in canned foodstuffs.
Boutakhrit K; Crisci M; Bolle F; Van Loco J
Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2011 Feb; 28(2):173-9. PubMed ID: 21246429
[TBL] [Abstract][Full Text] [Related]
40. Harmonization of Infliximab and Anti-Infliximab Assays Facilitates the Comparison Between Originators and Biosimilars in Clinical Samples.
Gils A; Van Stappen T; Dreesen E; Storme R; Vermeire S; Declerck PJ
Inflamm Bowel Dis; 2016 Apr; 22(4):969-75. PubMed ID: 26954707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
